09Jan/14

Mood stabilizing drug may help treat acute kidney injury – EurekAlert (press release)

Organ Failure

Counsel & Heal

Mood stabilizing drug may help treat acute kidney injury
EurekAlert (press release)
Washington, DC (January 9, 2014) — A mood stabilizer used to treat bipolar affective disorders may also help treat acute kidney injury, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Lithium May Help Treat Acute Kidney InjuryCounsel & Heal
New ray of hope for kidney patientsIndia.Com Health
Ray of hope for kidney patientsDaily News & Analysis

all 22 news articles »
09Jan/14

Mood Stabilizing Drug May Help Treat Acute Kidney Injury – Newswise (press release)

Organ Failure

Counsel & Heal

Mood Stabilizing Drug May Help Treat Acute Kidney Injury
Newswise (press release)
A single low dose of lithium given to mice following acute kidney injury promotes kidney repair and accelerates the recovery of kidney function. Acute kidney injury is one of the most common and serious complications of hospitalized patients. Newswise …
Lithium May Help Treat Acute Kidney InjuryCounsel & Heal
Lithium May Promote Recovery in Acute Kidney InjuryDoctors Lounge

all 22 news articles »
09Jan/14

Mood stabilizing drug may help treat acute kidney injury – Medical Xpress

Organ Failure

Counsel & Heal

Mood stabilizing drug may help treat acute kidney injury
Medical Xpress
A mood stabilizer used to treat bipolar affective disorders may also help treat acute kidney injury, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings are significant because …
Lithium May Help Treat Acute Kidney InjuryCounsel & Heal
Lithium May Promote Recovery in Acute Kidney InjuryDoctors Lounge
New ray of hope for kidney patientsIndia.Com Health
Daily News & Analysis
all 22 news articles »
09Jan/14

Researchers find comparable long-term outcomes between diastolic and systolic … – Medical Xpress

Organ Failure

Researchers find comparable long-term outcomes between diastolic and systolic …
Medical Xpress
A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes between congestive heart failure patients with preserved ejection fraction commonly known as “diastolic …
Participation rate problem in rehabStarPhoenix

all 5 news articles »
09Jan/14

Researchers find comparable long-term outcomes between diastolic and systolic … – Science Codex

Organ Failure

Researchers find comparable long-term outcomes between diastolic and systolic …
Science Codex
(Boston) – A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes between congestive heart failure patients with preserved ejection fraction commonly known as …
Participation rate problem in rehabStarPhoenix

all 5 news articles »
09Jan/14

Researchers find comparable long-term outcomes between diastolic and systolic … – EurekAlert (press release)

Organ Failure

Researchers find comparable long-term outcomes between diastolic and systolic …
EurekAlert (press release)
(Boston) – A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes between congestive heart failure patients with preserved ejection fraction commonly known as …

and more »
09Jan/14

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure – News-Medical.net

Organ Failure

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure
News-Medical.net
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company’s randomized, multi-center Phase 2b …
Trevena Announces Dosing of First Patient in Phase 2b BLAST-AHF Trial of …Businessweek

all 4 news articles »